2019
DOI: 10.1080/02770903.2019.1600144
|View full text |Cite
|
Sign up to set email alerts
|

Usefulness of mannitol challenge testing for diagnosing asthma in everyday clinical practice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
2
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 22 publications
0
2
0
Order By: Relevance
“…The PD15 and RDR are expressed as median (IQR) (non-parametrical variables), FEV1 is expressed as mean (SD) (parametrical variable), and the categorical variables are expressed as the number of Taking into account the possible overlap between exercise-induced and nocturnal asthma, we distributed our patients into four distinct groups, according to their clinical symptoms at baseline: Group 1: "Presence of both exercise-induced and nocturnal asthma symptoms" (n = 10); Group 2: "Only nocturnal asthma symptoms" (n = 3); Group 3: "Only exercise-induced asthma symptoms" (n = 6); and Group 4: "Absence of both exerciseinduced and nocturnal asthma symptoms" (n = 4). Despite the fact that the Kruskal-Wallis test did not demonstrate any significant difference in PD 15 between these groups (p = 0.15), children experiencing nocturnal symptoms (Group 1 and 2) tended to have lower PD 15 [Group 1: 470 mg (122-635); Group 2: 345 mg (177-490); Group 3: 635 mg (635-635); Group 4: 635 mg (503-635)], as depicted in Figure 3.…”
Section: Associations Between Pd 15 and Patient Characteristicsmentioning
confidence: 72%
See 1 more Smart Citation
“…The PD15 and RDR are expressed as median (IQR) (non-parametrical variables), FEV1 is expressed as mean (SD) (parametrical variable), and the categorical variables are expressed as the number of Taking into account the possible overlap between exercise-induced and nocturnal asthma, we distributed our patients into four distinct groups, according to their clinical symptoms at baseline: Group 1: "Presence of both exercise-induced and nocturnal asthma symptoms" (n = 10); Group 2: "Only nocturnal asthma symptoms" (n = 3); Group 3: "Only exercise-induced asthma symptoms" (n = 6); and Group 4: "Absence of both exerciseinduced and nocturnal asthma symptoms" (n = 4). Despite the fact that the Kruskal-Wallis test did not demonstrate any significant difference in PD 15 between these groups (p = 0.15), children experiencing nocturnal symptoms (Group 1 and 2) tended to have lower PD 15 [Group 1: 470 mg (122-635); Group 2: 345 mg (177-490); Group 3: 635 mg (635-635); Group 4: 635 mg (503-635)], as depicted in Figure 3.…”
Section: Associations Between Pd 15 and Patient Characteristicsmentioning
confidence: 72%
“…The MDP challenge has been demonstrated as a practical tool for BHR evaluation in clinical practice due to the combination of portability, reproducibility and high specificity in asthma diagnosis [13][14][15]. In addition, it has been suggested as a potential monitoring tool for assessing the impact of ICS prophylaxis on airway inflammation and BHR in asthmatic subjects [12,16].…”
Section: Introductionmentioning
confidence: 99%
“…The kit provided for the bronchial challenge test includes filled capsules of mannitol in increasing doses and a dry powder inhaler. The challenge is carried out as previously described [ 42 ]. An evaluation of the safety of mannitol as a bronchial challenge test has previously been published [ 43 ].…”
Section: Methodsmentioning
confidence: 99%
“…The kit provided for the bronchial challenge test includes lled capsules of mannitol in increasing doses and a dry powder inhaler. The challenge is carried out as previously described (41). An evaluation of the safety of mannitol as a bronchial challenge test has previously been published (42).…”
Section: Examination Program At Study Visitmentioning
confidence: 99%